Cited by 4Sleep and Wakefulness ResearchNeurotransmitter Receptor Influence on BehaviorNeuroscience of respiration and sleep

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

REM Sleep Function and Brain Monoamine Regulation

Rotenberg, Vadim S.·2006·Sleep and Sleep Disorders

Overview

Integrity signals

Registry

Crossref · 10.1007/0-387-27682-3_4

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 102

  1. Adrien J, Dugovic CH, Martin P. Sleep wakefulness patterns in helpless rats. Physiol Behav 1991; 49:257–262. · DOI
  2. Asakura W, Matsumoto K, Ohta H et al. Effect of alpha2-adrenergic drugs on REM sleep deprivation—induced increase in swimming activity. Pharmacol Biochem Behav 1993; 46:111–115. · DOI
  3. Asakura W, Matsumoto K, Ohta H et al. Monoamine depletion attenuates the REM sleep deprivation-induced increase in clonidine response in the forced swimming test. Pharmacol Biochem Behav 1994; 49:79–84. · DOI
  4. Asakura W, Matsumoto K, Jhta H et al. Involvement of dopamine D2 receptor mechanism in the REM sleep deprivation-induced increase in swimming activity in the forced swimming test. Pharmacol Biochem Behav 1994; 48:43–46. · DOI
  5. Asakura W, Matsumoto K, Watanabe H. REM sleep deprivation treatment enhances the effect of clozapine in the forced swimming test. Gen Pharmac 1995:26:1225–1228. · DOI
  6. Baldessarini RJ. Chemotherapy in psychiatry: Principles and practice. 2nd ed. Cambridge: Harvard University Press, 1985.
  7. Benington JH, Heller HC. Monoaminergic and cholinergic modulation of REM-sleep timing in rats. Brain Res 1995; 681:141–146. · DOI
  8. Benjamin J, Patterson Ch, Greenberg BD et al. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet 1996; 12:81–84. · DOI
  9. Beutler L, Ware J, Karacan I et al. Differentiating psychological characteristics of patients with sleep apnea and narcolepsy. Sleep 1981; 4:39–47. · DOI
  10. Cloninger CB, Adolfsson R, Svrakic NM. Mapping genes for human personality. Nat Genet 1996; 12:3–4. · DOI
  11. Coble PA, Kupfer DJ, Shaw DH. Distribution of REM latency in depression. Biol Psychiatry 1981; 16:453–466.
  12. Cohen RM, Pickar D, Garnett D et al. REM sleep suppression induced by selective monoamine oxidase inhibitors. Psychopharmacology (Berl) 1982; 78:137–140. · DOI
  13. Dement WC, Mitler MM, Henricksen SJ. Sleep changes during chronic administration of parachlorphenylalanine. Rev Can Biol 1972; 31:69–75.
  14. Ebstein RP, Novick O, Umansky R et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet 1996; 12:78–80. · DOI · Paper page
  15. Everson CA. Functional consequences of sustained sleep deprivation in the rat. Behav Brain Res 1995; 69:43–54. · DOI
  16. Feng P, Ma Y. Clomipramine suppresses postnatal REM sleep without increasing wakefulness: Implications for the production of depressive behaviors. Sleep 2002; 25:177–184. · DOI
  17. Fornal C, Auerbach S, Jacobs BL. Activity of serotonin-containing neurons in nucleus raphe magnus in freely moving cats. Exp Neurol 1985; 88:590–608. · DOI
  18. Gaillard JM. Brain catecholaminergic activity in relation to sleep. In: Priest RG, Pletscher A, Ward J, eds. Sleep Research: Proceedings of the Northern European Symposium on Sleep Research. Basle: 1979:35–41. · DOI
  19. Gillin JC, Wyatt RJ, Fram D et al. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacol (Berlin) 1978; 59:267–272. · DOI
  20. Gonzales MM, del C, Valatx JL et al. Role of the locus coeruleus on the mechanism of the sleep rebound. J Sleep Res 1994; 3(Suppl 1):92.
  21. Gonzalez MM, del C, Debilly G et al. Sleep increase after immobilization stress: Role of the noradrenergic locus coeruleus system in rat. Neuroscience Letters 1995; 202:5–8. · DOI
  22. Gottesmann C. The neurochemistry of waking and sleeping mental activity: The disinhibition-dopamine hypothesis. Psychiatry and Clinical Neurosciences 2002; 56:345–354. · DOI · Paper page
  23. Greenberg R. Where is the forest? Where is the dream? Behavioral and Brain Sciences 2000; 23:943–945. · DOI
  24. Greenberg R, Pearlman CH. The private language of the dream. In: J Natterson, ed. The dream in clinical practice. New York: Aronson, 1980; 85–96.
  25. Hartmann E. The Functions of Sleep. New Hawen, CT: Yale University Press, 1973.
  26. Hartmann E, Chung R, Draskoczy PR et al. Effects of 6-hydroxydopamine on sleep in the rat. Nature (Lond.) 1971; 233:425–427. · DOI
  27. Hartmann E, Russ D, Oldfield M et al. Dream content: Effects of L-DOPA. Sleep Research 1980; 9:153.
  28. Hobson JA, McCarley RW, Nelson JP. Location and spike-train characteristics of cells in anterodorsal pons having selective decreases in firing in rat during desynchronized sleep. J Neurophysiol 1983; 50:770–783. · DOI
  29. Jobert M, Jahnig P, Schulz H. Effect of two antidepressant drugs on REM sleep and EMG activity during sleep. Neuropsychobiology 1999; 39:101–109. · DOI
  30. Jones HM, Pilowsky LS. Dopamine and antipsychotic drug action revisited. British Journal of Psychiatry 2002; 181:271–275. · DOI
  31. Jones BE, Harper ST, Halaris AE. Effects of locus coeruleus lesions upon cerebral monoamine content, sleep wakefulness states and the response to amphetamine in the cat. Brain Res 1977; 124:473–496. · DOI
  32. Kafi S, Bouras C, Constantinidis J et al. Paradoxical sleep and brain catecholamines in the rat after single and repeated administration of alpha-methyl-parathyrosine. Brain Res 1977; 135:123–134. · DOI
  33. Kamamori N, Sakai K, Jouvet M. Neuronal activity specific to paradoxical sleep in the ventromedial medullary reticular formation of unrestrained cats. Brain Res 1980; 189:251–255. · DOI
  34. Kapur Sh. Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. American J Psychiatry 2003; 160:13–23. · DOI · Paper page
  35. Kinai T, Scerb JC. Mesencephalic reticular activating system and cortical acetylcholine output. Nature 1965; 205:80–82. · DOI
  36. Kramer M. The selective mood regulatory function of dreaming: An update and revision. In: Moffitt A, Kramer M, Hoffmann R, eds. The function of dreaming. New York, Albany: State University of New York Press, 1993:139–196.
  37. Kuiken D, Sikora S. The impact of dreams on waiking thoughts and feelings. In: Moffitt A, Kramer M, Hoffmann R, eds. The function of dreaming. New York: States University of New York Press, 1993:419–476.
  38. Kupfer DJ, Ulrich RF, Coble PA et al. The application of automated REM and slow wave sleep analysis (normal and depressives). Psychiatr Res 1984; 13:325–334. · DOI
  39. Landolt HP, de Boer LP. Effect of chronic phenelzine treatment on REM sleep: Report of three patients. Neuropsychopharmacology 2001; 25:S63–67. · DOI
  40. McGinty DJ, Harper KM. Dorsal raphe neurons depression of firing during sleep in cats. Brain Res 1976; 101:569–575. · DOI
  41. Mendelson WB, Gillin JCh, Wyatt RJ. Human sleep and its disorders. New York: Plenum Press, 1977. · DOI
  42. Mirmiran M, Van de Poll NE, Corner MA. Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: Effect upon adult sleep and behavior in the rat. Brain Res 1981; 204:129–146. · DOI
  43. Mogilnicka E, Pilc A. Rapid eye movement sleep deprivation inhibits clonidine-induced sedation in the rat. Europ J Pharmacol 1981; 71:123–126. · DOI
  44. Mogilnicka E, Boissard CG, Hunn C. Suppresant effect of REM sleep deprivation on neophobia in normal rats and in rats with selective DSP-4 induced damage of locus coeruleus neurons. Pharmacol Biochem Behav 1985; 23:93–97. · DOI
  45. Mollenhour MN, Voorhees JW, Davis SF. Sleepy and hostile: The effects of REM sleep deprivation on shock-elicited aggression. Anim Learn Behav 1977; 5:148–152. · DOI
  46. Morrison A. Central active states overview. In: Beckman AL, ed. The neural basis of behavior. New York: Spectrum, 1982:3–18. · DOI
  47. Nofzinger EA, Reynolds III CF, Thase ME et al. American J Psychiatry 1995; 152:274–276. · DOI · Paper page
  48. Ogilvie RD, Broughton RJ. Sleep deprivation and measures of emotionality in rat. Psychophysiology 1976; 13:249–260. · DOI
  49. Perez NM, Benedito MAC. Activities of monoamine oxidase (MAO) A and B in discrete regions of rat brain after rapid eye movement (REM) sleep deprivation. Pharmacol Biochem Behav 1997; 58:605–608. · DOI
  50. Piletz JE, Halaris A, Ernsberger PR. Psychopharmacology of imidazoline and alpha-2 adrenergic receptors: Implications for depression. Crit Rev Neurobiol 1994; 9:29–66.
  51. Purcell S, Moffitt A, Hoffmann R. Waking, dreaming and self-regulation. In: Moffitt MA, Kramer R, Hoffmann, eds. The functions of dreaming. New York, Albany: State University of New York Press, 1993:197–260
  52. Putkonen PTS. Alpha-and-beta-adrenergic mechanisms in the control of sleep stages. In: Priest RG, Pletscher A Ward J, eds. Sleep research: Proceedings of the Northern European Symposium on Sleep Research Basle. 1979:19–34. · DOI
  53. Putkonen P, Putkonen A. Suppression of paradoxical sleep following hypothalamic defense reactions in cats during normal conditions and recovery from PS deprivation. Brain Res 1971; 26:334–347. · DOI
  54. Putkonen PTS, Leppvuori A, Stenberg D. Paradoxical sleep inhibition by central alpha-2 adrenoreceptor stimulant, clonidine, antagonized by alpha-2 receptor blocker, yohimbine. Life Sciences 1977; 21:1059–1066. · DOI
  55. Radulovacki M, Micovic N. Effects of REM sleep deprivation and desipramine on beta-adrenergic binding sites in rat brain. Brain Res 1982; 235:393–396. · DOI
  56. Rasmussen K, Morilak DA, Jacobs BL. Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behavior and in response to simple and complex stimuli. Brain Res 1986; 371:324–334. · DOI
  57. Rechtschaffen A, Gilliland M, Bergmann B et al. Physiological correlates of prolonged sleep deprivation in rats. Science 1983; 221:182–184. · DOI · Paper page
  58. Reynolds CF III, Kupfer D. Sleep in depression. In: Williams RZ, Karacan I, Moore CA, eds. Sleep disorders, diagnosis and treatment. New York: John Wiley, 1988:147–164.
  59. Riemann D, Velthaus S, Laubenthal S et al. REM-suppressing effects of amitriptyline and amitriptyline N-oxide after acute medication in healthy volunteers: Results of two uncontrolled pilot trials. Pharmacopsychiatry 1990; 23:253–258. · DOI
  60. Ross RJ, Ball WA, Gresh PJ et al. REM sleep suppression by monoamine reuptake blockade: Development of tolerance with repeated drug administration. Biol Psychiatry 1990; 28:231–239. · DOI
  61. Ross RJ, Gresh PJ, Bull WA et al. REM sleep inhibition by desipramine: Evidence for an alpha-1-adrenergic mechanisms. Brain Res 1995; 701:129–34. · DOI
  62. Rotenberg VS. Search activity in the context of psychosomatic disturbances, of brain monoamines and REM sleep function. Pavlovian J Biolog Sci 1984; 19:1–15. · DOI
  63. Rotenberg VS. The nature of nonlinear relationship between the individual’s present state and his sleep structure. In: Koella W, Obal F, Schulz H, Visser P, eds. Sleep. Stuttgart and New York: Gustav Fischer Verlag, 1988a:86:134–137.
  64. Rotenberg VS. Functional deficiency of REM sleep and its role in the pathogenesis of neurotic and psychosomatic disturbances. Pavlovian J0 of Biological Science 1988b; 23:1–3. · DOI
  65. Rotenberg V. REM sleep and dreams as mechanism of search activity recovery. In: Moffitt A, Kramer M, Hoffmann R, eds. Function of Dreaming. New York: State University of New York press, 1993:261–292.
  66. Rotenberg VS. The revised monoamine hypothesis: Mechanism of antidepressant treatment in the context of behavior. Integr Physiol Behav Sci 1994; 29:182–188. · DOI
  67. Rotenberg VS. An integrative psychophysiological approach to brain hemisphere functions in schizophrenia. Neuroscience and Biobehavioral Reviews 1994; 18:487–495 · DOI
  68. Rotenberg VS. The psychobiological dream functions: A new solution for old contradiction. In: Rozenberg JJ, ed. Sense and Nonsense. Philosophical, clinical and ethical perspectives. The Magnes Press, the Hebrew University Jerusalem, 1996:187–197.
  69. Rotenberg VS. Learned helplessness and sleep: Discussion of contradictions. Homeostasis 1996; 37:89–92.
  70. Rotenberg VS. Sleep after immobilization stress and sleep deprivation: Common features and theoretical integration. Critical Reviews in Neurobiology 2000; 14:225–231. · DOI
  71. Rotenberg VS, Arshavsky VV. Search activity and its impact on experimental and clinical pathology. Activitas Nervosa Superior (Praha) 1979; 21:105–115.
  72. Rotenberg VS, Arshavsky VV. Psychophysiology of hemispheric asymmetry: The “entropy” of right hemisphere activity. Integr Physiol Behav Sci 1991; 26:183–188. · DOI
  73. Rotenberg VS, Boucsein W. Adaptive versus maladaptive emotional tension. Genet Soc Gen Psychol Monographs 1993; 119:207–232.
  74. Rotenberg VS, Sirota P, Elizur A. Psychoneuroimmunology: Searching for the main deteriorating psychobehavioral factor. Genet Soc Gen Psychol Monogr 1996; 122:329–346.
  75. Rotenberg VS, Kayumov L, Indursky P et al. REM sleep in depressed patients: Different attempts to achieve adaptation. J Psychosomati Res 1997; 42:565–575. · DOI
  76. Rotenberg VS, Shamir E, Barak Y et al. REM sleep latency and wakefulness in the first sleep cycle as markers of major depression. A controlled study vs. schizophrenia and normal controls. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2002; 26:1211–1215. · DOI
  77. Salamone JD, Cousins MS, Snyder BJ. Behavioral functions of nucleus accumbens dopamine: Empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 1997; 21:341–359. · DOI
  78. Sastre JP, Sakai K, Jouvet M. Persistance du sommeil paradoxal chez le chat après destruction de l’aire gigantocellulaire du tegmentum pontique par l’acide kainique. CR Acad Sci 1979; 289D:959–964.
  79. Schatzberg AF, Schildkraut JJ. Recent studies on norepinephrine systems in mood disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, 1995:911–920.
  80. Schenk CH, Mahowald MW, Kim SW et al. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 1992; 15:226–235. · DOI · Paper page
  81. Schittecatte M, Dumont F, Machowski R et al. Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: Implications for subsensitivity of alpha2-adrenergic receptors in depression. Psychiatry Research 2002; 109:1–8. · DOI
  82. Schwartz JC, Costentin J, Martres MP et al. Modulation of receptor mechanisms in the CNS: Hyper-and hyposensitivity to catecholamines. Neuropharmacology 1978; 17:665–685. · DOI
  83. Seligman MEP. Helplessness. On depression, development and death. San Fransisco: Greeman WH, 1975.
  84. Siegel JM, Wheeler RL, McGinty DJ. Activity of medullar reticular formation neurons in the unrestrained cat during waking and sleep. Brain Res 1979; 179:49–60. · DOI
  85. Siegel JM, Rogawski MA. A function for REM sleep: Regulation of noradrenergic receptor sensitivity. Brain Res Rev 1988; 13:213–233. · DOI
  86. Siegel JM, Tomaszewski KS, Nienhuis R. Behavioral organization of reticular formation: Studies in the unrestrained cat II. Cells related to facial movements. J Neurophysiol 1986; 50:17–723.
  87. Siever LJ, Davis KL. Overview: Towards a dysregulation hypothesis of depression. American Journal of Psychiatry 1985; 142:1017–1031. · DOI
  88. Simon RP, Gershon MD, Brooks DC. The role of the raphe nuclei in the regulation of ponto-geniculo-occipital wave activity. Brain Res 1973; 58:313–330. · DOI
  89. Soldatos CR, Stefanis CN, Bergiannaki JD et al. An experimental antidepressant increases REM sleep. Progr. Neuropsychopharmacol. Biol Psychiatry 1988; 12:899–907.
  90. Solms M. Dreaming and REM sleep are controlled by different brain mechanisms. Behavioral and Brain Sciences 2000; 23:843–850. · DOI · Paper page
  91. Stahl SM. Neurotransmission of cognition, pt I: Dopamine is a hitchhiker in frontal cortex: Norepinephrine transporters regulate dopamine (Brainstorms) J Clin Psychiatry 2003; 64:4–5. · DOI
  92. Steriade M, Hobson JA. Neuronal activity during the sleep-waking cycle. Progr Neurobiol 1976; 6:155–376. · DOI
  93. Tsai L-L, Bergmann BM, Perry BD. Effects of chronic total sleep deprivation on central noradrenergic receptors in rat brain. Brain Res 1993; 602:221–227. · DOI
  94. Vogel GW. Evidence for REM sleep deprivation as the mechanism of action of antidepressant drug. Prog Neuropsychopharmacol Biol Psychiatry 1983; 7:343–349. · DOI
  95. Vogel G, Hagler M. Effects of neonatally administered iprindole on adult behaviors of rats. Pharmacol Biochem Behav 1996; 55:157–161. · DOI
  96. Vogel G, Neill D, Koris D et al. REM sleep abnormalities in a new animal model of endogenous depression. Neurosci Biobehav Rev 1990; 14:77–83. · DOI
  97. Vogel G, Cohen J, Mullis D et al. Nefazodone and REM sleep: How do antidepressant drugs decrease REM sleep? Sleep 1998; 15:795–796.
  98. Wagner M, Mooney D. Personality characteristics of long and short sleepers. Journal of Clinical Psychology 1975; 31:434–436. · DOI
  99. Ware JC, McBrayer RH. REM sleep and nefazodone. Sleep 1998; 21:795–796. · DOI
  100. Wise RA, Colle LM. Pimozide attenuates free feeding: Best scores analysis reveals a motivational deficit. Psychopharmacology (Berl) 1984; 84:445–451.
  101. Wise RA, Spindler J, deWitt H et al. Neuroleptic induced “anhedonia” in rats: Pimozide blocks reward quality of food. Science 1978; 201:262–264. · DOI
  102. Woodward DJ, Moises HC, Waterhouse BD et al. Modulatory action of norepinephrine in the central nervous system. Federation Proceeding 1979; 38:2109–2116.

Cited by

Sorted by citations

See all 4

Metadata

Authors
Rotenberg, V. S.
Affiliations
Yehuda Abarbanel Mental Health Center (IL)
Corresponding author
Rotenberg, Vadim S.
Venue
Sleep and Sleep Disorders
Publisher
Springer US
Published
2006
Pages
27-35
OpenAlex
W2159581767
Cited by
4
References
2
Citations by year
2023: 1 · 2019: 2 · 2017: 1
FWCI
0.00
Type
book chapter
Language
en
Open access
closed
Locations
Springer eBooks (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
Keywords
REM sleep, brain monoamines, norepinephrine, dopamine, search activity, wakefulness, dream content

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review